Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 84 articles:
HTML format
Text format



Single Articles


    June 2018
  1. NIEUWENBURG SAV, Vuik FER, Kruip MJHA, Kuipers EJ, et al
    Effect of anticoagulants and NSAIDs on accuracy of faecal immunochemical tests (FITs) in colorectal cancer screening: a systematic review and meta-analysis.
    Gut. 2018 Jun 5. pii: gutjnl-2018-316344. doi: 10.1136/gutjnl-2018-316344.
    PubMed     Text format     Abstract available


    May 2018
  2. GLUCK N, Half EE, Bieber V, Schwartz D, et al
    Novel prep-less X-ray imaging capsule for colon cancer screening: a feasibility study.
    Gut. 2018 May 21. pii: gutjnl-2018-316127. doi: 10.1136/gutjnl-2018-316127.
    PubMed     Text format    


    April 2018
  3. SMITH T, Muller DC, Moons KGM, Cross AJ, et al
    Comparison of prognostic models to predict the occurrence of colorectal cancer in asymptomatic individuals: a systematic literature review and external validation in the EPIC and UK Biobank prospective cohort studies.
    Gut. 2018 Apr 3. pii: gutjnl-2017-315730. doi: 10.1136/gutjnl-2017-315730.
    PubMed     Text format     Abstract available


    March 2018
  4. JOO JE, Jayasekara H, Wong EM, Clendenning M, et al
    Assessing the ProMCol classifier as a prognostic marker for non-metastatic colorectal cancer within the Melbourne Collaborative Cohort Study.
    Gut. 2018 Mar 24. pii: gutjnl-2018-316122. doi: 10.1136/gutjnl-2018-316122.
    PubMed     Text format    


  5. RIGTER LS, Snaebjornsson P, Rosenberg EH, Atmodimedjo PN, et al
    Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.
    Gut. 2018;67:447-455.
    PubMed     Text format     Abstract available


  6. DAVENPORT JR, Su T, Zhao Z, Coleman HG, et al
    Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps.
    Gut. 2018;67:456-465.
    PubMed     Text format     Abstract available


    February 2018
  7. SUNDKVIST A, Myte R, Palmqvist R, Harlid S, et al
    Plasma ghrelin is probably not a useful biomarker for risk prediction or early detection of colorectal cancer.
    Gut. 2018 Feb 28. pii: gutjnl-2018-316110. doi: 10.1136/gutjnl-2018-316110.
    PubMed     Text format    


  8. CREMONESI E, Governa V, Garzon JFG, Mele V, et al
    Gut microbiota modulate T cell trafficking into human colorectal cancer.
    Gut. 2018 Feb 6. pii: gutjnl-2016-313498. doi: 10.1136/gutjnl-2016-313498.
    PubMed     Text format     Abstract available


  9. OVERWATER A, Kessels K, Elias SG, Backes Y, et al
    Endoscopic resection of high-risk T1 colorectal carcinoma prior to surgical resection has no adverse effect on long-term outcomes.
    Gut. 2018;67:284-290.
    PubMed     Text format     Abstract available


  10. RICHARDS CH, Ventham NT, Mansouri D, Wilson M, et al
    An evidence-based treatment algorithm for colorectal polyp cancers: results from the Scottish Screen-detected Polyp Cancer Study (SSPoCS).
    Gut. 2018;67:299-306.
    PubMed     Text format     Abstract available


    January 2018
  11. WILLIAMS DS, Mouradov D, Jorissen RN, Newman MR, et al
    Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
    Gut. 2018 Jan 30. pii: gutjnl-2017-315664. doi: 10.1136/gutjnl-2017-315664.
    PubMed     Text format     Abstract available


  12. DE ARCANGELIS A, Chamaillard M, Simon-Assmann P, Labouesse M, et al
    Integrin a6 loss promotes colitis-associated colorectal cancer. Response to: "Integrin a6 variants and colorectal cancer" by Beaulieu JF.
    Gut. 2018 Jan 3. pii: gutjnl-2017-315727. doi: 10.1136/gutjnl-2017-315727.
    PubMed     Text format    


  13. BACKES Y, Schwartz MP, Ter Borg F, Wolfhagen FHJ, et al
    Multicentre prospective evaluation of real-time optical diagnosis of T1 colorectal cancer in large non-pedunculated colorectal polyps using narrow band imaging (the OPTICAL study).
    Gut. 2018 Jan 3. pii: gutjnl-2017-314723. doi: 10.1136/gutjnl-2017-314723.
    PubMed     Text format     Abstract available


  14. LAWLER M, Alsina D, Adams RA, Anderson AS, et al
    Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.
    Gut. 2018;67:179-193.
    PubMed     Text format     Abstract available


  15. CARBALLAL S, Maisterra S, Lopez-Serrano A, Gimeno-Garcia AZ, et al
    Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD.
    Gut. 2018;67:70-78.
    PubMed     Text format     Abstract available


    December 2017
  16. DEMING DA
    Tailoring the colorectal cancer disease assessment to the treatment strategy.
    Gut. 2017 Dec 21. pii: gutjnl-2017-315394. doi: 10.1136/gutjnl-2017-315394.
    PubMed     Text format    


  17. SIEVERS CK, Zou LS, Pickhardt PJ, Matkowskyj KA, et al
    Subclonal diversity arises early even in small colorectal tumours and contributes to differential growth fates.
    Gut. 2017;66:2132-2140.
    PubMed     Text format     Abstract available


    November 2017
  18. WAN L, Yu W, Shen E, Sun W, et al
    SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.
    Gut. 2017 Nov 7. pii: gutjnl-2017-314983. doi: 10.1136/gutjnl-2017-314983.
    PubMed     Text format     Abstract available


  19. GUNDERT M, Edelmann D, Benner A, Jansen L, et al
    Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier).
    Gut. 2017 Nov 3. pii: gutjnl-2017-314711. doi: 10.1136/gutjnl-2017-314711.
    PubMed     Text format     Abstract available


  20. ZORZI M, Hassan C, Capodaglio G, Fedato C, et al
    Long-term performance of colorectal cancer screening programmes based on the faecal immunochemical test.
    Gut. 2017 Nov 3. pii: gutjnl-2017-314753. doi: 10.1136/gutjnl-2017-314753.
    PubMed     Text format     Abstract available


    October 2017
  21. MAZARD T, Boonsirikamchai P, Overman MJ, Asran MA, et al
    Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab.
    Gut. 2017 Oct 30. pii: gutjnl-2017-313786. doi: 10.1136/gutjnl-2017-313786.
    PubMed     Text format     Abstract available


  22. BEAULIEU JF
    Integrin alpha6 variants and colorectal cancer.
    Gut. 2017 Oct 28. pii: gutjnl-2017-315415. doi: 10.1136/gutjnl-2017-315415.
    PubMed     Text format    


  23. SCHRAMM C, Janhsen K, Demir M, Nierhoff D, et al
    Serrated polyposis syndrome may go undiagnosed even in structured colorectal cancer screening programmes performed by endoscopists with otherwise good quality indices.
    Gut. 2017 Oct 21. pii: gutjnl-2017-315321. doi: 10.1136/gutjnl-2017-315321.
    PubMed     Text format    


  24. FLEMER B, Warren RD, Barrett MP, Cisek K, et al
    The oral microbiota in colorectal cancer is distinctive and predictive.
    Gut. 2017 Oct 7. pii: gutjnl-2017-314814. doi: 10.1136/gutjnl-2017-314814.
    PubMed     Text format     Abstract available


  25. BARAULT L, Amatu A, Siravegna G, Ponzetti A, et al
    Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.
    Gut. 2017 Oct 5. pii: gutjnl-2016-313372. doi: 10.1136/gutjnl-2016-313372.
    PubMed     Text format     Abstract available


    August 2017
  26. DIGBY J, Fraser CG, Carey FA, Steele RJC, et al
    Can the performance of a quantitative FIT-based colorectal cancer screening programme be enhanced by lowering the threshold and increasing the interval?
    Gut. 2017 Aug 24. pii: gutjnl-2017-314862. doi: 10.1136/gutjnl-2017-314862.
    PubMed     Text format    


  27. KHAN K, Rata M, Cunningham D, Koh DM, et al
    Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study.
    Gut. 2017 Aug 8. pii: gutjnl-2017-314178. doi: 10.1136/gutjnl-2017-314178.
    PubMed     Text format     Abstract available


  28. ROBERTS SK
    Train-the-trainer education and colonoscopy quality indicators: where to now?
    Gut. 2017;66:1533-1534.
    PubMed     Text format    


    July 2017
  29. YANG W, Liu L, Masugi Y, Qian ZR, et al
    Calcium intake and risk of colorectal cancer according to expression status of calcium-sensing receptor (CASR).
    Gut. 2017 Jul 4. pii: gutjnl-2017-314163. doi: 10.1136/gutjnl-2017-314163.
    PubMed     Text format     Abstract available


  30. EAST JE, Atkin WS, Bateman AC, Clark SK, et al
    British Society of Gastroenterology position statement on serrated polyps in the colon and rectum.
    Gut. 2017;66:1181-1196.
    PubMed     Text format     Abstract available


    June 2017
  31. HAWINKELS LJ, Hardwick JC
    Putting the Wnt up colon cancer.
    Gut. 2017;66:983-984.
    PubMed     Text format    


  32. ADAMS LA, Anstee QM, Tilg H, Targher G, et al
    Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.
    Gut. 2017;66:1138-1153.
    PubMed     Text format     Abstract available


  33. BUCHANAN DD, Clendenning M, Zhuoer L, Stewart JR, et al
    Lack of evidence for germline RNF43 mutations in patients with serrated polyposis syndrome from a large multinational study.
    Gut. 2017;66:1170-1172.
    PubMed     Text format    


    May 2017
  34. OMAR AL-HASSI H, Ng O, Brookes M
    Tumour-associated and non-tumour-associated microbiota in colorectal cancer.
    Gut. 2017 May 4. pii: gutjnl-2017-314219. doi: 10.1136/gutjnl-2017-314219.
    PubMed     Text format    


  35. PARANG B, Kaz AM, Barrett CW, Short SP, et al
    BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis.
    Gut. 2017;66:852-862.
    PubMed     Text format     Abstract available


  36. REES CJ, Rajasekhar PT, Wilson A, Close H, et al
    Narrow band imaging optical diagnosis of small colorectal polyps in routine clinical practice: the Detect Inspect Characterise Resect and Discard 2 (DISCARD 2) study.
    Gut. 2017;66:887-895.
    PubMed     Text format     Abstract available


    April 2017
  37. MANIC G, Signore M, Sistigu A, Russo G, et al
    CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells.
    Gut. 2017 Apr 7. pii: gutjnl-2016-312623. doi: 10.1136/gutjnl-2016-312623.
    PubMed     Text format     Abstract available


  38. DE BARRIOS O, Gyorffy B, Fernandez-Acenero MJ, Sanchez-Tillo E, et al
    ZEB1-induced tumourigenesis requires senescence inhibition via activation of DKK1/mutant p53/Mdm2/CtBP and repression of macroH2A1.
    Gut. 2017;66:666-682.
    PubMed     Text format     Abstract available


  39. FLEMER B, Lynch DB, Brown JM, Jeffery IB, et al
    Tumour-associated and non-tumour-associated microbiota in colorectal cancer.
    Gut. 2017;66:633-643.
    PubMed     Text format     Abstract available


  40. ARNOLD M, Sierra MS, Laversanne M, Soerjomataram I, et al
    Global patterns and trends in colorectal cancer incidence and mortality.
    Gut. 2017;66:683-691.
    PubMed     Text format     Abstract available


  41. PELLISE M, Burgess NG, Tutticci N, Hourigan LF, et al
    Endoscopic mucosal resection for large serrated lesions in comparison with adenomas: a prospective multicentre study of 2000 lesions.
    Gut. 2017;66:644-653.
    PubMed     Text format     Abstract available


  42. AMICARELLA F, Muraro MG, Hirt C, Cremonesi E, et al
    Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer.
    Gut. 2017;66:692-704.
    PubMed     Text format     Abstract available


  43. HUR K, Toiyama Y, Okugawa Y, Ide S, et al
    Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.
    Gut. 2017;66:654-665.
    PubMed     Text format     Abstract available


    March 2017
  44. SAKUMA K, Sasaki E, Kimura K, Komori K, et al
    HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of CD44 during epithelial-mesenchymal transition.
    Gut. 2017 Mar 30. pii: gutjnl-2016-312927. doi: 10.1136/gutjnl-2016-312927.
    PubMed     Text format     Abstract available


  45. SHAH MS, DeSantis TZ, Weinmaier T, McMurdie PJ, et al
    Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer.
    Gut. 2017 Mar 24. pii: gutjnl-2016-313189. doi: 10.1136/gutjnl-2016-313189.
    PubMed     Text format     Abstract available


  46. KINROSS J
    Race-specific differences in mucosal sulfidogenic bacteria modify colon cancer risk.
    Gut. 2017 Mar 20. pii: gutjnl-2017-313989. doi: 10.1136/gutjnl-2017-313989.
    PubMed     Text format    


  47. MENNONNA D, Maccalli C, Romano MC, Garavaglia C, et al
    T cell neoepitope discovery in colorectal cancer by high throughput profiling of somatic mutations in expressed genes.
    Gut. 2017;66:454-463.
    PubMed     Text format     Abstract available


  48. VAN DOORN SC, van der Vlugt M, Depla A, Wientjes CA, et al
    Adenoma detection with Endocuff colonoscopy versus conventional colonoscopy: a multicentre randomised controlled trial.
    Gut. 2017;66:438-445.
    PubMed     Text format     Abstract available


  49. GUPTA S, Jacobs ET, Baron JA, Lieberman DA, et al
    Risk stratification of individuals with low-risk colorectal adenomas using clinical characteristics: a pooled analysis.
    Gut. 2017;66:446-453.
    PubMed     Text format     Abstract available


  50. MOLLER P, Seppala T, Bernstein I, Holinski-Feder E, et al
    Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.
    Gut. 2017;66:464-472.
    PubMed     Text format     Abstract available


    February 2017
  51. SIRAJ AK, Masoodi T, Bu R, Pratheeshkumar P, et al
    MED12 is recurrently mutated in Middle Eastern colorectal cancer.
    Gut. 2017 Feb 9. pii: gutjnl-2016-313334. doi: 10.1136/gutjnl-2016-313334.
    PubMed     Text format     Abstract available


  52. YAZICI C, Wolf PG, Kim H, Cross TL, et al
    Race-dependent association of sulfidogenic bacteria with colorectal cancer.
    Gut. 2017 Feb 2. pii: gutjnl-2016-313321. doi: 10.1136/gutjnl-2016-313321.
    PubMed     Text format     Abstract available


  53. RADAELLI F, Paggi S, Hassan C, Senore C, et al
    Split-dose preparation for colonoscopy increases adenoma detection rate: a randomised controlled trial in an organised screening programme.
    Gut. 2017;66:270-277.
    PubMed     Text format     Abstract available


  54. IJSPEERT JE, Rana SA, Atkinson NS, van Herwaarden YJ, et al
    Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis.
    Gut. 2017;66:278-284.
    PubMed     Text format     Abstract available


  55. CHIU SY, Chuang SL, Chen SL, Yen AM, et al
    Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program.
    Gut. 2017;66:293-300.
    PubMed     Text format     Abstract available


  56. ROY HK, Turzhitsky V, Wali R, Radosevich AJ, et al
    Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin.
    Gut. 2017;66:285-292.
    PubMed     Text format     Abstract available


    January 2017
  57. TULCHINSKY E
    Colorectal cancer cells use the negative feedback regulators of WNT signalling to activate epithelial-mesenchymal transition pathways.
    Gut. 2017 Jan 12. pii: gutjnl-2016-313185. doi: 10.1136/gutjnl-2016-313185.
    PubMed     Text format    


  58. DE KLERK CM, Gupta S, Dekker E, Essink-Bot ML, et al
    Socioeconomic and ethnic inequities within organised colorectal cancer screening programmes worldwide.
    Gut. 2017 Jan 10. pii: gutjnl-2016-313311. doi: 10.1136/gutjnl-2016-313311.
    PubMed     Text format     Abstract available


  59. BETTINGTON M, Walker N, Rosty C, Brown I, et al
    Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma.
    Gut. 2017;66:97-106.
    PubMed     Text format     Abstract available


  60. OKUGAWA Y, Toiyama Y, Toden S, Mitoma H, et al
    Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
    Gut. 2017;66:107-117.
    PubMed     Text format     Abstract available


  61. YU J, Feng Q, Wong SH, Zhang D, et al
    Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.
    Gut. 2017;66:70-78.
    PubMed     Text format     Abstract available


  62. KAPIDZIC A, van Roon AH, van Leerdam ME, van Vuuren AJ, et al
    Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer.
    Gut. 2017;66:118-123.
    PubMed     Text format     Abstract available


    December 2016
  63. PASSAMONTI B, Malaspina M, Fraser CG, Tintori B, et al
    A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (FIT). Assessment of test performance and adherence in a single round of a population-based screening programme for colorectal cancer.
    Gut. 2016 Dec 14. pii: gutjnl-2016-312716. doi: 10.1136/gutjnl-2016-312716.
    PubMed     Text format     Abstract available


    November 2016
  64. COLUSSI D, Zagari RM, Morini B, Fabbri M, et al
    Prevalence of serrated polyposis syndrome in an FIT-based colorectal cancer screening cohort in Italy.
    Gut. 2016 Nov 15. pii: gutjnl-2016-313063. doi: 10.1136/gutjnl-2016-313063.
    PubMed     Text format    


  65. HUANG Y, Zhou J, Luo S, Wang Y, et al
    Identification of a fluorescent small-molecule enhancer for therapeutic autophagy in colorectal cancer by targeting mitochondrial protein translocase TIM44.
    Gut. 2016 Nov 14. pii: gutjnl-2016-311909. doi: 10.1136/gutjnl-2016-311909.
    PubMed     Text format     Abstract available


  66. RHO JH, Ladd JJ, Li CI, Potter JD, et al
    Protein and glycomic plasma markers for early detection of adenoma and colon cancer.
    Gut. 2016 Nov 7. pii: gutjnl-2016-312794. doi: 10.1136/gutjnl-2016-312794.
    PubMed     Text format     Abstract available


    October 2016
  67. NULSEN B, Lewis B
    Response to: 'Full-spectrum (FUSE) versus standard forward-viewing colonoscopy in an organised colorectal cancer screening programme' by Hassan et al.
    Gut. 2016 Oct 24. pii: gutjnl-2016-313117. doi: 10.1136/gutjnl-2016-313117.
    PubMed     Text format    


  68. DOWNING A, Morris EJ, Corrigan N, Sebag-Montefiore D, et al
    High hospital research participation and improved colorectal cancer survival outcomes: a population-based study.
    Gut. 2016 Oct 19. pii: gutjnl-2015-311308. doi: 10.1136/gutjnl-2015-311308.
    PubMed     Text format     Abstract available


  69. DOUBENI CA, Corley DA, Quinn VP, Jensen CD, et al
    Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study.
    Gut. 2016 Oct 12. pii: gutjnl-2016-312712. doi: 10.1136/gutjnl-2016-312712.
    PubMed     Text format     Abstract available


    September 2016
  70. BOROVSKI T, Vellinga TT, Laoukili J, Santo EE, et al
    Inhibition of RAF1 kinase activity restores apicobasal polarity and impairs tumour growth in human colorectal cancer.
    Gut. 2016 Sep 26. pii: gutjnl-2016-311547. doi: 10.1136/gutjnl-2016-311547.
    PubMed     Text format     Abstract available


  71. LINDNER AU, Salvucci M, Morgan C, Monsefi N, et al
    BCL-2 system analysis identifies high-risk colorectal cancer patients.
    Gut. 2016 Sep 23. pii: gutjnl-2016-312287. doi: 10.1136/gutjnl-2016-312287.
    PubMed     Text format     Abstract available


    August 2016
  72. GROBBEE EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, et al
    A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening.
    Gut. 2016 Aug 9. pii: gutjnl-2016-311819. doi: 10.1136/gutjnl-2016-311819.
    PubMed     Text format     Abstract available


  73. HASSAN C, Senore C, Radaelli F, De Pretis G, et al
    Full-spectrum (FUSE) versus standard forward-viewing colonoscopy in an organised colorectal cancer screening programme.
    Gut. 2016 Aug 9. pii: gutjnl-2016-311906. doi: 10.1136/gutjnl-2016-311906.
    PubMed     Text format     Abstract available


    July 2016
  74. GRILLET F, Bayet E, Villeronce O, Zappia L, et al
    Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture.
    Gut. 2016 Jul 25. pii: gutjnl-2016-311447. doi: 10.1136/gutjnl-2016-311447.
    PubMed     Text format     Abstract available


  75. SONG M, Zhang X, Meyerhardt JA, Giovannucci EL, et al
    Marine omega-3 polyunsaturated fatty acid intake and survival after colorectal cancer diagnosis.
    Gut. 2016 Jul 19. pii: gutjnl-2016-311990. doi: 10.1136/gutjnl-2016-311990.
    PubMed     Text format     Abstract available


  76. DE ARCANGELIS A, Hamade H, Alpy F, Normand S, et al
    Hemidesmosome integrity protects the colon against colitis and colorectal cancer.
    Gut. 2016 Jul 1. pii: gutjnl-2015-310847. doi: 10.1136/gutjnl-2015-310847.
    PubMed     Text format     Abstract available


    May 2016
  77. MASUGI Y, Nishihara R, Yang J, Mima K, et al
    Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.
    Gut. 2016 May 5. pii: gutjnl-2016-311421. doi: 10.1136/gutjnl-2016-311421.
    PubMed     Text format     Abstract available


    April 2016
  78. KAMINSKI MF, Anderson J, Valori R, Kraszewska E, et al
    Leadership training to improve adenoma detection rate in screening colonoscopy: a randomised trial.
    Gut. 2016;65:616-24.
    PubMed     Text format     Abstract available


    March 2016
  79. ADAMI HO, Bretthauer M, Emilsson L, Hernan MA, et al
    The continuing uncertainty about cancer risk in inflammatory bowel disease.
    Gut. 2016 Mar 23. pii: gutjnl-2015-311003. doi: 10.1136/gutjnl-2015-311003.
    PubMed     Text format    


  80. BURGESS NG, Pellise M, Nanda KS, Hourigan LF, et al
    Clinical and endoscopic predictors of cytological dysplasia or cancer in a prospective multicentre study of large sessile serrated adenomas/polyps.
    Gut. 2016;65:437-46.
    PubMed     Text format     Abstract available


  81. FACCIORUSSO A, Ferrusquia J, Muscatiello N
    Lead time bias in estimating survival outcomes.
    Gut. 2016;65:538-9.
    PubMed     Text format    


    February 2016
  82. SONG M, Nishihara R, Wang M, Chan AT, et al
    Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status.
    Gut. 2016;65:296-304.
    PubMed     Text format     Abstract available


  83. COUGNOUX A, Delmas J, Gibold L, Fais T, et al
    Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria.
    Gut. 2016;65:278-85.
    PubMed     Text format     Abstract available


  84. DORIA-ROSE VP, Levin TR, Palitz A, Conell C, et al
    Ten-year incidence of colorectal cancer following a negative screening sigmoidoscopy: an update from the Colorectal Cancer Prevention (CoCaP) programme.
    Gut. 2016;65:271-7.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: